View in a different locale / language
Exome sequencing is a cost-effective alternative to whole genome sequencing, targeting the protein coding region of the genome accountable for a wide range of known disease-associated variants. As these variants can contribute to both Mendelian and common polygenic diseases, such as Alzheimer's disease, whole exome sequencing has been applied both in academic research and as a clinical diagnostic.
Eurofins Genomics' comprehensive human whole exome sequencing service provides researchers with a high-quality, affordable and convenient solution for identifying clinically and biologically relevant genetic variants.
5-7 weeks from receipt of samples and all required project information. Turnaround time may vary depending on project scope, data volume, technology selected, number of samples, and overall project complexity. The estimated timeline assumes no unforeseen biological or technical challenges during sample processing.